The most common form of lung cancer is primarily found in non-smokers, a new study reveals. Doctors react to the surprising ...

Despite the established links between inflammation and cancer development, the effects of inflammatory signaling on cancer ...

"By reproducing cancer cell-stroma and cell-matrix interactions, this model enhances the accuracy of drug response predictions and reduces unnecessary drug administration to non-responsive patients." ...

The proportion of people who have never smoked being diagnosed with lung cancer is rising, with new research pointing to air pollution as a growing contributor to lung cancer around the world.

Air pollution is fuelling a rise in the most common form of lung cancer among non-smokers, hitting women and people in Southeast Asia particularly hard, according to a study published on Tuesday ...

which tragically has an even worse prognosis than non-small cell lung cancer. We believe that radioligand therapy could offer a powerful new way to treat this disease by targeting the diseased tissue ...

Ahituv and his post-doc at the time, Hai Nguyen, PhD, were aware of studies that showed exposure to cold could suppress cancer in mice. One experiment even showed it could help a patient with ...

Patient-derived MPM cell cultures (n=16) exhibited stemness features and reflected intratumour and interpatient heterogeneity. A subset of the cells were subjected to high-throughput drug screening ...

Lung cancer screening aims to find lung cancer early. This is when there are more treatment options available and there is the best chance of treating it successfully. In the UK, the National ...

9 Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, China Objective Metastasis is the major cause of cancer death. However, what types of heterogenous cancer cells ...

1Department of Obstetrics and Gynecology, Peking University Third Hospital, China 2Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, China. 3Biobank, Peking ...

The authors provide convincing evidence that P63+ progenitor cell therapy can be safely delivered in patients with ILD, warranting movement to a Phase 2. However, given that this is a Phase 1 study ...